Fibrin Glue Sac Filling for Preventing Type II Endoleak, Short-Term Outcomes of a Prospective Randomized Controlled Trial

医学 纤维蛋白胶 外科 随机对照试验 腔内修复术 腹主动脉瘤 不利影响 相伴的 前瞻性队列研究 血管造影 动脉瘤 放射科 内科学
作者
Yonghui Chen,Lei Zhang,Zongwei Liu,Jiaxue Bi,Fang Niu,Xiaoxing Zhang,Qingsheng Lu,Xiangchen Dai
出处
期刊:Journal of Endovascular Therapy [SAGE]
卷期号:: 152660282311592-152660282311592 被引量:1
标识
DOI:10.1177/15266028231159245
摘要

Type II endoleak (T2EL) worsens the long-term results of endovascular aneurysm repair (EVAR). How to prevent T2ELs remains controversial. This study aimed to evaluate the efficacy and safety of fibrin glue sac filling (FGSF) to prevent T2ELs after EVAR.A prospective randomized controlled trial was conducted. Patients were randomly divided into group A (standard EVAR + FGSF) and group B (standard EVAR). The follow-up plans included outpatient or telephone consultation at 1 and 3 months and computed tomography (CT) angiography at 6 months, 1 year, and once a year after EVAR.A total of 64 abdominal aortic aneurysm (AAA) patients were randomized to the 2 groups. All patients were followed up for more than 6 months. The 2 groups showed similar baseline characteristics. The rate of T2ELs on immediate angiography in group A (9.6%) was significantly lower than that in group B (33.3%, p=0.033). Moreover, the sac area change was significantly reduced in group A at 6 months after EVAR (p=0.021). However, T2EL incidence was similar at the 6-month (p=0.055) and 1-year (p=0.057) follow-ups, and AAA diameter change was also similar at 1 year. There were similar operation times, radiation doses, severe adverse events (SAEs), and reinterventions between the 2 groups.Fibrin glue sac filling could prevent short-term type II endoleaks and promote AAA shrinkage after 6 months. The FGSF procedure is swift and straightforward; however, patients are at risk of bowel ischemia, especially after previous bowel resections or concomitant superior mesenteric artery (SMA) disease.Standard endovascular aneurysm repair (EVAR) couldn't prevent type II endoleak (T2EL). In this study, we found fibrin glue sac filling (FGSF) could prevent T2EL and promote AAA shrinkage in a short term. And the FGSF procedure is easy, it will be a useful supplement to standard EVAR for clinicians. And FGSF might have potential usefulness on ruptured aneurysms, although without direct evidence.Fibrin glue is often used to hemostasis and tissue adhesion in surgical patients and burn patients, we firstly carry out a randomized controlled study and prove that fibrin glue sac filling could prevent T2EL and promote sac remodeling.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzq完成签到,获得积分10
刚刚
落后世界完成签到,获得积分10
1秒前
数据删除发布了新的文献求助10
1秒前
来日可期发布了新的文献求助10
1秒前
fissh关注了科研通微信公众号
2秒前
wer完成签到,获得积分10
2秒前
李志达发布了新的文献求助10
3秒前
3秒前
陀思妥耶夫斯基完成签到 ,获得积分10
3秒前
3秒前
4秒前
4秒前
上官若男应助哈哈哈呢采纳,获得10
4秒前
同力力力完成签到,获得积分10
5秒前
5秒前
wxliao1234完成签到,获得积分10
6秒前
AnkHan完成签到,获得积分10
6秒前
麦麦脆汁猪完成签到 ,获得积分10
7秒前
7秒前
舒化奶完成签到,获得积分10
7秒前
zzz完成签到,获得积分10
7秒前
CipherSage应助小鱼鱼Fish采纳,获得20
8秒前
8秒前
美好斓发布了新的文献求助10
8秒前
英姑应助会笑的猪猪猫采纳,获得10
8秒前
同力力力发布了新的文献求助10
9秒前
9秒前
完美世界应助HELEN采纳,获得10
9秒前
小二郎应助别先生采纳,获得10
9秒前
润华完成签到 ,获得积分10
10秒前
李志达完成签到,获得积分10
10秒前
QXS发布了新的文献求助10
10秒前
wu完成签到,获得积分20
10秒前
zeannezg完成签到 ,获得积分10
10秒前
zhu发布了新的文献求助10
11秒前
我是老大应助瘦瘦盼旋采纳,获得10
11秒前
as完成签到,获得积分10
11秒前
深山何处钟声鸣完成签到,获得积分0
12秒前
TL发布了新的文献求助20
12秒前
霸气凝云发布了新的文献求助10
12秒前
高分求助中
Evolution 3rd edition 1500
Lire en communiste 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Elastic local buckling behaviour of corroded cold-formed steel columns 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
2-Acetyl-1-pyrroline: an important aroma component of cooked rice 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3180500
求助须知:如何正确求助?哪些是违规求助? 2830796
关于积分的说明 7981033
捐赠科研通 2492477
什么是DOI,文献DOI怎么找? 1329555
科研通“疑难数据库(出版商)”最低求助积分说明 635745
版权声明 602954